title: (-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways.
abstract: OBJECTIVE
  In the wake of intracerebral hemorrhage (ICH), a devastating stroke with no effective treatment, hemoglobin/iron-induced oxidative injury leads to neuronal loss and poor neurologic outcomes. (-)-Epicatechin (EC), a brain-permeable flavanol that modulates redox/oxidative stress via the NF-E2-related factor (Nrf) 2 pathway, has been shown to be beneficial for vascular and cognitive function in humans. Here, we examined whether EC can reduce early brain injury in ICH mouse models and investigated the underlying mechanisms.
  
  
  METHODS
  ICH was induced by injecting collagenase, autologous blood, or thrombin into mouse striatum. EC was administered orally at 3 h after ICH and then every 24 h. Lesion volume, neurologic deficits, brain edema, reactive oxygen species, and protein expression and activity were evaluated.
  
  
  RESULTS
  EC significantly reduced lesion volume and ameliorated neurologic deficits in both male and female ICH mice. Cell death and neuronal degeneration were decreased in the perihematomal area and were associated with reductions in caspase-3 activity and HMGB-1 level. These changes were accompanied by attenuation of oxidative insults, increased phase II enzyme expression, and increased Nrf2 nuclear accumulation. Interestingly, in addition to providing neuroprotection via Nrf2 signaling, EC diminished heme oxygenase-1 induction and brain iron deposition via an Nrf2-independent pathway that downregulated ICH-induced activating protein-1 activation and decreased matrix metalloproteinase 9 activity, lipocalin-2 levels, iron-dependent cell death, and ferroptosis-related gene expression.
  
  
  CONCLUSIONS
  Collectively, our data show that EC protects against ICH by activation of Nrf2-dependent and -independent pathways and may serve as a potential intervention for patients with ICH.
authors.affiliation: Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
authors.forename: Che-Feng
authors.initials: CF
authors.lastname: Chang
authors.affiliation: Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
authors.forename: Suzy
authors.initials: S
authors.lastname: Cho
authors.affiliation: Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
authors.forename: Jian
authors.initials: J
authors.lastname: Wang
keywords: (−)-Epicatechin; NF-E2-related factor 2; ferroptosis; heme oxygenase-1; iron
references.citation: FEBS Lett. 2014 Jan 3;588(1):79-85
references.pmid: 24269680
references.citation: Eur J Pharmacol. 2013 Sep 5;715(1-3):147-53
references.pmid: 23747595
references.citation: Brain. 2005 Jul;128(Pt 7):1622-33
references.pmid: 15800021
references.citation: J Cereb Blood Flow Metab. 2011 May;31(5):1243-50
references.pmid: 21102602
references.citation: Nat Cell Biol. 2002 May;4(5):E131-6
references.pmid: 11988758
references.citation: J Immunol. 2012 Aug 15;189(4):1911-9
references.pmid: 22786765
references.citation: Mediators Inflamm. 2010;2010:
references.pmid: 20936104
references.citation: Stroke. 1998 Oct;29(10):2136-40
references.pmid: 9756595
references.citation: Biochemistry. 2000 Feb 29;39(8):1935-41
references.pmid: 10684642
references.citation: Stroke. 2002 Jul;33(7):1882-8
references.pmid: 12105370
references.citation: Free Radic Biol Med. 2002 Dec 15;33(12):1693-702
references.pmid: 12488137
references.citation: Stroke. 2012 Feb;43(2):524-31
references.pmid: 22076006
references.citation: Stroke. 2009 Jun;40(6):2244-50
references.pmid: 19246690
references.citation: BMJ. 1996 Feb 24;312(7029):478-81
references.pmid: 8597679
references.citation: Stroke. 2003 Dec;34(12):2964-9
references.pmid: 14615611
references.citation: J Neurotrauma. 1995 Oct;12(5):833-42
references.pmid: 8594211
references.citation: Kidney Int. 2012 May;81(10):969-982
references.pmid: 22278021
references.citation: Arch Biochem Biophys. 2012 Nov 15;527(2):113-8
references.pmid: 22425757
references.citation: J Cereb Blood Flow Metab. 2000 Feb;20(2):396-404
references.pmid: 10698078
references.citation: Nat Rev Mol Cell Biol. 2002 Mar;3(3):207-14
references.pmid: 11994741
references.citation: J Neurochem. 2012 Oct;123(2):325-36
references.pmid: 22881289
references.citation: Lancet Neurol. 2009 Apr;8(4):355-69
references.pmid: 19233729
references.citation: Neurobiol Dis. 2012 Jan;45(1):388-94
references.pmid: 21930208
references.citation: J Alzheimers Dis. 2013;36(1):21-40
references.pmid: 23531502
references.citation: Free Radic Biol Med. 2007 Aug 1;43(3):408-14
references.pmid: 17602956
references.citation: J Agric Food Chem. 2012 Sep 19;60(37):9377-83
references.pmid: 22953747
references.citation: Neurol Clin. 2013 Aug;31(3):721-35
references.pmid: 23896501
references.citation: Nature. 2012 Oct 11;490(7419):187-91
references.pmid: 23060188
references.citation: Stroke. 2005 Feb;36(2):193-5
references.pmid: 15625289
references.citation: J Cereb Blood Flow Metab. 2012 Apr;32(4):612-27
references.pmid: 22293989
references.citation: Stroke. 2013 May;44(5):1369-74
references.pmid: 23493733
references.citation: Stroke. 2009 May;40(5):1842-8
references.pmid: 19265047
references.citation: Am J Pathol. 2011 Apr;178(4):1749-61
references.pmid: 21435456
references.citation: Br J Clin Pharmacol. 2013 Mar;75(3):716-27
references.pmid: 22775434
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1025-32
references.pmid: 12376503
references.citation: J Neurosurg. 2005 Jul;103(1):97-103
references.pmid: 16121980
references.citation: FASEB J. 2008 Mar;22(3):659-61
references.pmid: 17942826
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10919-24
references.pmid: 9380735
references.citation: Nat Med. 2006 Apr;12(4):441-5
references.pmid: 16565723
references.citation: J Cereb Blood Flow Metab. 2007 May;27(5):894-908
references.pmid: 17033693
references.citation: Stroke. 2002 Nov;33(11):2636-41
references.pmid: 12411654
references.citation: Arch Pharm Res. 2009 Jan;32(1):149-54
references.pmid: 19183888
references.citation: J Cereb Blood Flow Metab. 2004 May;24(5):487-94
references.pmid: 15129180
references.citation: Lancet Neurol. 2010 Feb;9(2):133-4
references.pmid: 20056490
references.citation: Ann Neurol. 2011 Dec;70(6):920-31
references.pmid: 22190365
references.citation: J Clin Neurosci. 2011 Oct;18(10):1392-5
references.pmid: 21782444
references.citation: Prog Neurobiol. 2010 Dec;92(4):463-77
references.pmid: 20713126
references.citation: Brain. 2007 Jun;130(Pt 6):1643-52
references.pmid: 17525142
references.citation: J Cereb Blood Flow Metab. 2011 Nov;31(11):2135-51
references.pmid: 21863040
references.citation: Nat Rev Neurosci. 2004 Nov;5(11):863-73
references.pmid: 15496864
references.citation: J Cardiovasc Pharmacol. 2001 Dec;38(6):875-84
references.pmid: 11707691
references.citation: Clin Exp Pharmacol Physiol. 2012 Mar;39(3):265-73
references.pmid: 22229384
references.citation: Stroke. 1996 Dec;27(12):2312-9; discussion 2319-20
references.pmid: 8969799
references.citation: Stroke. 2013 Jun;44(6 Suppl 1):S74-8
references.pmid: 23709738
references.citation: Neuropharmacology. 2011 Oct-Nov;61(5-6):975-80
references.pmid: 21752338
references.citation: Eur J Pharmacol. 2009 Aug 15;616(1-3):122-7
references.pmid: 19540227
references.citation: Lancet Neurol. 2006 Jan;5(1):53-63
references.pmid: 16361023
references.citation: Stroke. 2007 Dec;38(12):3280-6
references.pmid: 17962605
references.citation: Brain. 2009 Jan;132(Pt 1):26-36
references.pmid: 18772219
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6087-92
references.pmid: 12721362
references.citation: Toxicol Sci. 2001 Jan;59(1):169-77
references.pmid: 11134556
references.citation: J Neurol Sci. 2012 Oct 15;321(1-2):1-10
references.pmid: 22857988
references.citation: Carcinogenesis. 1999 Nov;20(11):2137-42
references.pmid: 10545417
references.citation: Prog Neurobiol. 2006 Apr;78(6):347-63
references.pmid: 16716487
references.citation: Neurology. 2005 Feb 22;64(4):725-7
references.pmid: 15728302
references.citation: Stroke. 2009 Mar;40(3 Suppl):S90-1
references.pmid: 19064798
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1024-9
references.pmid: 16418281
references.citation: Brain Res. 2013 Apr 10;1505:86-92
references.pmid: 23416150
references.citation: J Neurochem. 2006 Apr;97(2):527-36
references.pmid: 16539659
references.citation: J Cereb Blood Flow Metab. 2010 Dec;30(12):1951-61
references.pmid: 20442725
references.citation: Stroke. 2007 Feb;38(2 Suppl):759-62
references.pmid: 17261733
references.citation: J Biol Chem. 1995 May 19;270(20):11977-84
references.pmid: 7538129
references.citation: J Neurosci. 2007 May 30;27(22):5869-78
references.pmid: 17537957
references.citation: Food Funct. 2011 Jan;2(1):39-44
references.pmid: 21773584
references.citation: Free Radic Biol Med. 2012 Nov 15;53(10):1894-902
references.pmid: 22985936
references.citation: Cell. 2012 May 25;149(5):1060-72
references.pmid: 22632970
references.citation: J Agric Food Chem. 2012 Sep 12;60(36):8823-30
references.pmid: 22440087
references.citation: Free Radic Res. 2008 Apr;42(4):297-304
references.pmid: 18404528
references.citation: Neurobiol Dis. 2008 Aug;31(2):242-9
references.pmid: 18571425